Physiological and clinical significance of enterochromaffin-like cell activation in the regulation of gastric acid secretion

World Journal of Gastroenterology

Volumn 13, Issue 4, 2007, Pages 493-496

  Cui, Guanglin ^a   Waldum, Helge L ^b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Enterochromaffin like cell; Gastric acid; Gastric carcinoid; Gastrin; Rebound acid hypersecretion

Indexed keywords

ACETYLCHOLINE; CHOLECYSTOKININ B RECEPTOR; GALANIN; GASTRIN; GLUCOSE REGULATED PROTEIN; GLYCINE; HISTAMINE; HISTAMINE H2 RECEPTOR ANTAGONIST; HISTIDINE DECARBOXYLASE; HYDROCHLORIC ACID; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR 1; OMEPRAZOLE; PEPTIDE YY; PROGASTRIN; PROTON PUMP INHIBITOR; RANITIDINE; SOMATOSTATIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ACID SECRETION; CELL ACTIVATION; DYSPEPSIA; ENTEROCHROMAFFIN LIKE CELL; ENZYME ACTIVITY; ENZYME REGULATION; GASTRIN CELL; HISTAMINE RELEASE; HUMAN; HYPERGASTRINEMIA; IRON ABSORPTION; NONHUMAN; REFLUX ESOPHAGITIS; REVIEW; SIDE EFFECT; SOMATOSTATIN CELL; STOMACH; STOMACH ACID; STOMACH ACID SECRETION; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH CARCINOID; STOMACH DISEASE; STOMACH PARIETAL CELL;

EID: 33846809058     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i4.493     Document Type: Review

References (67)

1. Hakanson R, Alumets J, Ekelund M, Hedenbro J, Liedberg G, Loren I, Sundler F, Vallgren S. Stimulation of gastric acid secretion. Scand J Gastroenterol Suppl 1979; 55: 21-28
2. Martinsen TC, Bergh K, Waldum HL. Gastric juice: a barrier against infectious diseases. Basic Clin Pharmacol Toxicol 2005; 96: 94-102
3. Fujita T, Kobayashi S. Structure and function of gut endocrine cells. Int Rev Cytol Suppl 1977; 6:187-233
4. Solcia E, Rindi G, Buffa R, Fiocca R, Capella C. Gastric endocrine cells: types, function and growth. Regul Pept 2000; 93:31-35
5. Sundler F, Bottcher G, Ekblad E, Hakanson R. The neuroendocrine system of the gut. Acta Oncol 1989; 28:303-314
6. Hakanson R, Owman C, Sporrong B, Sundler F. Electron microscopic identification of the histamine-storing argyrophil (enterochromaffin-like) cells in the rat stomach. Z Zellforsch Mikrosk Anat 1971; 122: 460-466
7. Capella C, Vassallo G, Sokia E. Light and electron microscopic identification of the histamine-storing argyrophil (ECL) cell in murine stomach and of its equivalent in other mammals. Z Zellforsch Mikrosk Anat 1971; 118: 68-84
8. Hakanson R, Bottcher G, Ekblad E, Panula P, Simonsson M, Dohlsten M, Hallberg T, Sundler F. Histamine in endocrine cells in the stomach. A survey of several species using a panel of histamine antibodies. Histochemistry 1986; 86:5-17
9. Hersey SJ, Sachs G. Gastric acid secretion. Physiol Rev 1995; 75: 155-189
10. Geibel JP, Wagner C. An update on acid secretion. Reu Physiol Biochem Pharmacol 2006; 156: 45-60
11. Schubert ML. Gastric secretion. Curr Opin Gastroenterol 2005; 21:636-643
12. Sandvik AK, Waldum HL, Kleveland PM, Schulze Sognen B. Gastrin produces an immediate and dose-dependent histamine release preceding acid secretion in the totally isolated, vascularly perfused rat stomach. Scand J Gastroenterol 1987; 22: 803-808
13. Hakanson R, Chen D, Tielemans Y, Andersson K, Ryberg B, Sundler F, Mattsson H. ECL cells: biology and pathobiology. Digestion 1994; 55 Suppl 3: 38-45
14. Waldum HL, Sandvik AK, Brenna E, Petersen H. Gastrin histamine sequence in the regulation of gastric acid secretion. Gut 1991; 32:698-701
15. Sawada M, Dickinson CJ. The G cell. Annu Rev Physiol 1997; 59:273-298
16. Mulholland MK Debas HT. Physiology and pathophysiology of gastrin: a review. Surgery 1988; 103: 135-147
17. Sandvik AK, Waldum HL. Aspects of the regulation of gastric histarrdne release. Scand J Gastroenterol Suppl 1991; 180: 108-112
18. Waldum HL, Sandvik AK, Brenna E, Kleveland PM. The gastrin-histamine sequence. Gastroenterology 1996; 111: 838-839
19. Sandvik AX, Waldum HL. CCK-B (gastrin) receptor regulates gastric histamine release and acid secretion. Am J Physiol 1991; 260: G925-G928
20. Ding XQ, Lindstrom E, Hakanson R. Time-course of deactivation of rat stomach ECL cells following cholecystokinin B/gastrin receptor blockade. Br J Pharmacol 1997; 122:1-6
21. Brenna E, Waldum HL. Studies of isolated parietal and enterochromaffin-like cells from the rat. Scand J Gastroenterol 1991; 26: 1295-1306
22. Chuang CN, Tanner M, Chen MC, Davidson S, Soll AH. Gastrin induction of histamine release from primary cultures of canine oxyntic mucosal cells. Am J Physiol 1992; 163: G460-G465
23. Prinz C, Scott DR, Hurwitz D, Helander HF, Sachs G. Gastrin effects on isolated rat enterochromaffin-like cells in primary culture. Am J Physiol 1994; 267: G663-G675
24. Sandvik AK, Dimaline R, Marvik R, Brenna E, Waldum HL. Gastrin regulates histidine decarboxylase activity and mRNA abundance in rat oxyntic mucosa. Am J Physiol 1994; 267: G254-G258
25. Hocker M, Zhang Z, Koh TJ, Wang TC. The regulation of histidine decarboxylase gene expression. Yale J Biol Med 1996; 69: 21-33
26. Dimaline R, Sandvik AK. Histidine decarboxylase gene expression in rat fundus is regulated by gastrin. FEBS Lett 1991; 281: 20-22
27. Brenna E, Hakanson R, Sundler F, Sandvik AK, Waldum HL. The effect of omeprazole-induced hypergastrinemia. on the oxyntic mucosa of mastomys. Scand J Gastroenterol 1991; 26: 667-672
28. Kleveland PM, Waldum HL, Larsson H. Gastric acid secretion in the totally isolated, vascularly perfused rat stomach. A selective muscarinic-1 agent does, whereas gastrin does not, augment maximal histamine-stimulated acid secretion. Scand J Gastroenterol 1987; 22: 705-713
29. Chen D, Zhao CM, Dockray GJ, Varro A, Van Hoek A, Sinclair NF, Wang TC, Koh TJ. Glycine-extended gastrin synergizes with gastrin 17 to stimulate acid secretion in gastrin-deficient mice. Gastroenterology 2000; 119: 756-765
30. Cui G, Koh TJ, Chen D, Zhao CM, Takaishi S, Dockray GJ, Varro A, Rogers AB, Fox JG, Wang TC. Overexpression of glycine-extended gastrin inhibits parietal cell loss and atrophy in the mouse stomach. Cancer Res 2004; 64: 8160-8166
31. Sandvik AK, Dockray GJ. Biological activity of carboxy-terminal gastrin analogs. Eur J Pharmacol 1999; 364: 199-203
32. Cui GL, Sandvik AK, Munkvold B, Waldum HL. Glycine-extended gastrin-17 stimulates acid secretion only via CCK-2 receptor-induced histamine release in the totally isolated vascularly perfused rat stomach. Acta Physiol Scand 2002, 174: 125-130
33. Ekblad E, Mei Q, Sundler F. Innervation of the gastric mucosa. Microsc Res Tech 2000; 48: 241-257
34. Walsh JH. Peptides as regulators of gastric acid secretion. Annu Rev Physiol 1988; 50:41-63
35. Sandor A, Kidd M, Lawton GP, Miu K, Tang LH, Modlin IM. Neurohormonal modulation of rat enterochromaffin-like cell histamine secretion. Gastroenterology 1996; 110: 1084-1092
36. Pisegna JR, Ohning GV, Athmann C, Zeng N, Walsh JH, Sachs G. Role of PACAP1 receptor in regulation of ECL cells and gastric add secretion by pituitary adenylate cyclase activating peptide. Ann N Y Acad Sci 2000; 921: 233-241
37. Zeng N, Walsh JH, Kang T, Wu SV, Sachs G. Peptide YY inhibition of rat gastric enterochromaffin-like cell function. Gastroenterology 1997; 112: 127-135
38. Zeng N, Kang T, Wen Y, Wong H, Walsh J, Sachs G. Galanin inhibition of enterochromaffin-like cell function. Gastroenterology 1998; 115: 330-339
39. Zeng N, Athmann C, Kang T, Lyu RM, Walsh JH, Ohning GV, Sachs G, Pisegna JR. PACAP type I receptor activation regulates ECL cells and gastric acid secretion. J Clin Invest 1999; 104:1383-1391
40. Lindstrom E, Eliasson L, Bjorkqvist M, Hakanson R. Gastrin and the neuropeptide PACAP evoke secretion from rat stomach histamine-containing (ECL) cells by stimulating influx of Ca2+ through different Ca2+ channels. J Physiol 2001; 535:663-677
41. Lauff JM, Modlin IM, Tang LH. Biological relevance of pituitary adenylate cyclase-activating polypeptide (PACAP) in the gastrointestinal tract. Regul Pept 1999; 84: 1-12
42. Sandvik AK, Cui G, Bakke I, Munkvold B, Waldum HL. PACAP stimulates gastric acid secretion in the rat by inducing histamine release. Am J Physiol Gastrointest Liver Physiol 2001; 281: G997-G1003
43. Larsson LI, Goltermann N, de Magistris L, Rehfeld JF, Schwartz TW. Somatostatin cell processes as pathways for paracrine secretion. Science 1979; 205: 1393-1395
44. Shin JM, Cho YM, Sachs G. Chemistry of covalent inhibition of the gastric (H+, K+)-ATPase by proton pump inhibitors. J Am Chem Soc 2004; 126: 7800-7811
45. Israel DM, Hassall E. Omerprazole and other proton pump inhibitors: pharmacology, efficacy, and safety, with special reference to use in children. J Pediatr Gastroenterol Nutr 1998; 27: 568-579
46. Larsson H, Carlsson E, Ryberg B, Fryklund J, Wallmark B. Rat parietal cell function after prolonged inhibition of gastric acid secretion. Am J Physiol 1988; 254: G33-G39
47. Fullarton GM, McLauchlan G, Macdonald A, Crean GP, McColl KE. Rebound nocturnal hypersecretion after four weeks treatment with an H2 receptor antagonist. Gut 1989; 30: 449-454
48. Waldum HL, Arnestad JS, Brenna E, Eide I, Syversen U, Sandvik AK. Marked increase in gastric acid secretory capacity after omeprazole treatment. Gut 1996; 39: 649-653
49. El-Omar E, Banerjee S, Wirz A, Penman I, Ardill JE, McColl KE. Marked rebound acid hypersecretion after treatment with ranitidine. Am J Gastroenterol 1996; 91: 355-359
50. Gillen D, Wirz AA, Ardill JE, McColl KE. Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status. Gastroenterology 1999; 116: 239-247
51. Kuipers EJ, Klinkenberg-Knol EC. Helicobacter pylori, acid, and omeprazole revisited: bacterial eradication and rebound hypersecretion. Gastroenterology 1999; 116:479-483
52. Qvigstad G, Waldum H. Rebound hypersecretion after inhibition of gastric acid secretion. Basic Clin Pharmacol Toxicol 2004; 94: 202-208
53. Fossmark R, Johnsen G, Johanessen E, Waldum HL. Rebound acid hypersecretion after long-term inhibition of gastric acid secretion. Aliment Pharmacol Ther 2005; 21: 149-154
54. Dockray GJ. Topical review. Gastrin and gastric epithelial physiology. J Physiol 1999; 518 (Pt 2): 315-324
55. Hakanson R, Oscarson J, Sundler F. Gastrin and the trophic control of gastric mucosa. Scand J Gastroenterol Suppl 1986; 118: 18-30
56. Koh TJ, Chen D. Gastrin as a growth factor in the gastrointestinal tract. Regul Pept 2000; 93: 37-44
57. Waldum HL, Brenna E, Sandvik AK. Relationship of ECL cells and gastric neoplasia. Yale J Biol Med 1998; 71: 325-335.
58. Waldum HL, Sandvik AK, Idle JR. Gastrin is the most important factor in ECL tumorigenesis. Gastroenterology 1998; 114:1113-1115
59. Cui G, Qvigstad G, Falkmer S, Sandvik AK, Kawase S, Waldum HL. Spontaneous ECLomas in cotton rats (Sigmodon hispidus): tumours occurring in hypoacidic/hypergastrinaemic animals with normal parietal cells. Carcinogenesis 2000; 21: 23-27
60. Dawson R, Manson JM. Orneprazole in oesophageal reflux disease. Lancet 2000; 356: 1770-1771
61. Attila T, Santharam R, Blom D, Komorowski R, Koch TR. Multifocal gastric carcinoid tumor in a patient with pernicious anemia receiving lansoprazole. Dig Dis Sci 2005; 50: 509-513
62. Ferrand A, Wang TC. Gastrin and cancer: a review. Cancer Lett 2006; 238:15-29
63. Aly A, Shulkes A, Baldwin GS. Gash-ins, cholecystokinins and gastrointestinal cancer. Biochim Biophys Acta 2004; 1704: 1-10
64. Takhar AS, Eremin O, Watson SA. The role of gastrin in colorectal carcinogenesis. Surgeon 2004; 2: 251-257
65. Rengifo-Cam W, Singh P. Role of progastrins and gastrins and their receptors in GI and pancreatic cancers: targets for treatment. Curr Pharm Des 2004; 10: 2345-2358
66. Kinoshita Y, Ishihara S, Kadowaki Y, Fukui H, Chiba T. Reg protein is a unique growth factor of gastric mucosal cells. J Gastroenterol 2004; 39: 507-513
67. Sekikawa A, Fukui H, Fujii S, Takeda. J, Nanakin A, Hisatsune H, Seno H, Takasawa S, Okamoto H, Fujimori T, Chiba T. REG Ialpha. protein may function as a trophic and/or anti-apoptotic factor in the development of gastric cancer. Gastroenterology 2005; 128: 642-653